Your browser doesn't support javascript.
loading
Icosapent ethyl following acute coronary syndrome: the REDUCE-IT trial.
Sayah, Neila; Bhatt, Deepak L; Miller, Michael; Brinton, Eliot A; Jacobson, Terry A; Ketchum, Steven B; Jiao, Lixia; Pineda, Armando Lira; Doyle, Ralph T; Tardif, Jean Claude; Ballantyne, Christie M; Steg, Ph Gabriel.
Afiliación
  • Sayah N; Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, 46 Rue Henri Huchard, 75018 Paris, France.
  • Bhatt DL; Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai Health, New York, NY, USA.
  • Miller M; Department of Medicine, Crescenz Veterans Affairs Medical Center and University of Pennsylvania School of Medicine, Philadelphia, PA, USA.
  • Brinton EA; Utah Lipid Center, Salt Lake City, UT, USA.
  • Jacobson TA; Lipid Clinic and Cardiovascular Risk Reduction Program, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
  • Ketchum SB; Amarin Pharma, Inc. (Amarin), Bridgewater, NJ, USA.
  • Jiao L; Amarin Pharma, Inc. (Amarin), Bridgewater, NJ, USA.
  • Pineda AL; Amarin Pharma, Inc. (Amarin), Bridgewater, NJ, USA.
  • Doyle RT; Amarin Pharma, Inc. (Amarin), Bridgewater, NJ, USA.
  • Tardif JC; Montreal Heart Institute, Université de Montréal, Montreal, Québec, Canada.
  • Ballantyne CM; Department of Medicine, Baylor College of Medicine, and the Texas Heart Institute, Houston, TX, USA.
  • Steg PG; Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, 46 Rue Henri Huchard, 75018 Paris, France.
Eur Heart J ; 45(13): 1173-1176, 2024 Apr 01.
Article en En | MEDLINE | ID: mdl-38252107

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Hipertrigliceridemia / Ácido Eicosapentaenoico / Inhibidores de Hidroximetilglutaril-CoA Reductasas / Síndrome Coronario Agudo Límite: Humans Idioma: En Revista: Eur Heart J Año: 2024 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Hipertrigliceridemia / Ácido Eicosapentaenoico / Inhibidores de Hidroximetilglutaril-CoA Reductasas / Síndrome Coronario Agudo Límite: Humans Idioma: En Revista: Eur Heart J Año: 2024 Tipo del documento: Article País de afiliación: Francia